Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib

Clinical trial NCT00784667 · UNKNOWN

Trial details

NCT number: NCT00784667
Sponsor: Austin Health
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2008-10-01
Primary completion: 2010-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.